|
Clinical Site’s Problems Won’t Trip Up Launch of First HIV Home Test
An FDA warning letter issued to a researcher involved in clinical trials of the first home HIV test is not expected to affect the product’s marketing, officials from the FDA and the test’s manufacturer tell D&DL.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives